Antidiabetic effects of Embelia ribes extract in high fat diet and low dose streptozotocin-induced type 2 diabetic rats

Frontiers in Life Science

Volumn 7, Issue 3-4, 2013, Pages 186-196

  Bhandari, Uma ^a   Chaudhari, Hemantkumar Somabhai ^a   Khanna, Geetika ^b   Najmi, Abul Kalam ^a  

^a HAMDARD UNIVERSITY   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

adiponectin; high fat diet; leptin; lipase; oxidative stress; type 2 diabetes

Indexed keywords

EID: 84899524297     PISSN: 21553769     EISSN: 21553777     Source Type: Journal    
DOI: 10.1080/21553769.2014.881304     Document Type: Article

References (37)

1. Alladi S, Shanmugasundaram KR. 1989. Induction of hypercholesterolaemia by supplementing soy protein with acetate generating amino-acids. Nutr Rep Int. 40:893-899.
2. Baginski ES, Foa PP, Zak B. 1967. Determination of rat liver microsomal glucose-6-phosphatase activity: study of citrate and G-6-P inhibition. Anal Biochem. 21:201-207. doi: 10.1016/0003-2697(67)90181-9
3. Bhandari U, Chaudhari HS, Bisnoi AN, Kumar V, Khanna G, Javed K. 2013. Anti-obesity effect of standardized ethanol extract of Embelia ribes in murine model of high fat diet-induced obesity. PharmaNutrition. 1:50-57. doi: 10.1016/j.phanu.2013.01.001
4. Bhandari U, Jain N, Ansari MN, Pillai KK. 2008. Beneficial effect of Embelia ribes ethanolic extract on blood pressure and glycosylated hemoglobin in streptozotocin-induced diabetes in rats. Fitoterapia. 79:351-355. doi: 10.1016/j.fitote.2008.04.001
5. Bhandari U, Jain N, Pillai KK. 2007. Further studies on antioxidant potential and protection of pancreatic β-cells by Embelia ribes in experimental diabetes. Exp Diabetes Res. 2007:1-6. doi: 10.1155/2007/15803
6. Bhandari U, Kanojia R, Pillai KK. 2002. Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. Int J Exp Diab Res. 3:159-162. doi: 10.1080/15604280214278
7. Birari RB, Bhutani KK. 2007. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 12:879-889. doi: 10.1016/j.drudis.2007.07.024
8. Brown JL, Spicer MT, Spicer LJ. 2002. Effect of high-fat diet on body composition and hormone responses to glucose tolerance tests. Endocrine. 19:327-332. doi: 10.1385/ENDO:19:3:327
9. Calberg I, Mannerviek B. 1975. Glutathione reductase levels in rat brain. J Biol Chem. 250:5475-5480.
10. Caliborne AL. 1985. Assay of catalase. In: Greenwald RA, editor. Handbook of methods of oxygen radical research. London, UK: Bacoraton, CRC Press; p. 283-285.
11. Chaudhari HS, Bhandari U, Khanna G. 2012. Preventive effect of embelin from Embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. Planta Med. 78:651-657. doi: 10.1055/s-0031-1298379
12. HDL). Clin Biochem. 34:583-588. doi: 10.1016/S0009-9120(01)00263-6
13. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. 1987. Insulin resistance in essential hypertension. New Engl J Med. 317:350-357. doi: 10.1056/NEJM198708063170605
14. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499-502.
15. Gaikwad AB, Viswanad B, Ramarao P. 2007. PPARγ agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res. 55:400-407. doi: 10.1016/j.phrs.2007.01.015
16. Gupta OP, Ali MM, Ray Ghatak BJ, Atal CK. 1977. Some pharmacological investigations of embelin and its semisynthetic derivatives. Indian J Physiol Pharmacol. 21:31-39.
17. Haffner SM. 1998. Management of dyslipidemia in adults with diabetes. Diabetes Care. 21:160-178. doi: 10.2337/diacare.21.1.160
18. Hamza N, Berke B, Cheze C, Agli AN, Robinson P, Gin H, Moore N. 2010. Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol. 128:513-518. doi: 10.1016/j.jep.2010.01.004
19. Kennedy AL, Lyons TJ. 1997. Glycation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism. 46:14-21. doi: 10.1016/S0026-0495(97)90311-5
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem. 193:265-275.
21. Madhavan SN, Arimboor R, Arumughan C. 2011. RP-HPLC-DAD method for the estimation of embelin as marker in Embelia ribes and its polyherbal formulations. Biomed Chromatogr. 25:600-605. doi: 10.1002/bmc.1489
22. Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469-474. doi: 10.1111/j.1432-1033.1974.tb03714.x
23. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. 2007. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 40:163-173. doi: 10.3164/jcbn.40.163
24. Morita T, Oh-hashi A, Takei K, Ikai M, Kasaoka S, Kiriyama S. 1997. Cholesterol-lowering effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet. J Nutr. 127:470-477.
25. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal Biochem. 95:359-364. doi: 10.1016/0003-2697(79)90738-3
26. Pushparaj PN, Low HK, Manikandan J, Tan BK, Tan CH. 2007. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J Ethnopharmacol. 111:430-434. doi: 10.1016/j.jep.2006.11.028
27. Shetty P. 2012. India's diabetes time bomb. Nature. 485:S14-S16. doi: 10.1038/485S14a
28. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. 2005. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 52:313-320. doi: 10.1016/j.phrs.2005.05.004
29. Stalmans W, Bollen M, Mvumbi L. 1991. Control of glycogen synthesis in health and disease. Diabetes Metab Rev. 3:127-161. doi: 10.1002/dmr.5610030107
30. Stumvoll M, Goldstein BJ, van Haeften TW. 2005. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 365:1333-1346. doi: 10.1016/S0140-6736(05)61032-X
31. Tripathi SN, Tiwari CM, Upadhyay BN, Singh RS. 1979. Screening of hypoglycemic action in certain indigenous drugs. J Res Indian Med Yoga Homeopath. 14:159-169
32. Vander-Vries J. 1954. Two methods for the determination of glycogen in liver. Biochem J. 57:410-416.
33. Vasseur F, Meyre D, Froguel P. 2006. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med. 8:1-12. doi: 10.1017/S1462399406000147
34. Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L. 2011. Hypoglycemic and insulin-sensitizing effects of berberine in high -fat diet- and streptozotocin-induced diabetic rats. Metab Clin Exp. 60:298-305. doi: 10.1016/j.metabol.2010.02.005
35. Yaturu S. 2011. Obesity and type 2 diabetes. J. Diabetes Mellitus. 1:79-95. doi: 10.4236/jdm.2011.14012
36. Zhang L, Yang J, Chen X, Zan K, Wen X, Chen H, Wang Q, Lai MX. 2010. Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. J Ethnopharmacol. 132:518-524. doi: 10.1016/j.jep.2010.08.053
37. Zheng T, Shu G, Yang Z, Mo S, Zhao Y, Mei Z. 2012. Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats. J Ethnopharmacol. 139:814-821. doi: 10.1016/j.jep.2011.12.025